• Home
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us
    • 繁
    • 简
繁 简
  • About Us
    • Company Profile
    • Corporate Structure
    • Milestones
  • Core Business
    • R&D and Production Base
      • Zhuhai R&D and Production Base
      • Kunming R&D and Production Base
      • Global Sales Network
    • Chinese Medicine Development
      • Chinese Medicine R&D
      • Chinese Medicinal Materials
      • Decoction Slices
    • Biomedical Technology and Products
      • Tianda Products
      • Pipeline
    • Quality Healthcare Services
  • Investor Relations
    • Corporate Information
    • Corporate Governance
    • Announcements & Circulars
    • Financial Statements
    • Shares and Details
    • Investor Calendar
    • Investor Enquiries
    • Email Alerts
    • Notices (Replacement of Lost Share Certificates)
    • Dissemination of Corporate Communications
  • Sustainability
    • Our Sustainable Development
    • ESG Report
  • Careers
    • Wort At Tianda
    • Recruitment
      • Vacancies
      • Internship Programmes
      • Trainee Programmes
  • Media Centre
    • Press Releases
    • Media Coverage
    • Contact Us

2023
  • Select Year
    1. 2025
    2. 2024
    3. 2023
    4. 2022
    5. 2021
    6. 2020
    7. 2019
    8. 2018
    9. 2017
    10. 2016
    11. 2015
    12. 2014
    13. 2013
    14. 2012
    15. 2011
    16. 2010
    17. 2009
    18. 2008
    19. 2007
  • 01.12.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November, 2023

  • 09.11.2023

    Announcements and Notices - [Results of EGM/SGM] POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 9 NOVEMBER 2023

  • 01.11.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October, 2023

  • 18.10.2023

    Documents on Display Documents on Display

  • 18.10.2023

    Proxy Forms Proxy form for use at the extraordinary general meeting (the "EGM") of Tianda Pharmaceuticals Limited to be held on Thursday, 9 November 2023 at 10:30 a.m. (or at any adjournment thereof)

  • 18.10.2023

    Announcements and Notices - [Notice of EGM/SGM] NOTICE OF EXTRAORDINARY GENERAL MEETING

  • 18.10.2023

    Circulars - [Continuing Connected Transaction] (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH; (II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH; AND (III) NOTICE OF EXTRAORDINARY GENERAL MEETING

  • 12.10.2023

    Announcements and Notices - [Delay in Dispatch of Circular or other Document / Continuing Connected Transaction] DELAY IN DESPATCH OF CIRCULAR

  • 03.10.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September, 2023

  • 20.09.2023

    Announcements and Notices - [Continuing Connected Transaction] (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH AND (II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH

  • 04.09.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August, 2023

  • 29.08.2023

    Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

  • 28.08.2023

    Announcements and Notices - [Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member] RESIGNATION OF NON-EXECUTIVE DIRECTOR; APPOINTMENT OF NON-EXECUTIVE DIRECTOR; AND CHANGE IN COMPOSITION OF BOARD COMMITTEES

  • 28.08.2023

    Announcements and Notices - [Interim Results] 2023 INTERIM RESULTS ANNOUNCEMENT

  • 23.08.2023

    Announcements and Notices - [Profit Warning / Inside Information] PROFIT ALERT - REDUCTION IN LOSS

  • 16.08.2023

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 01.08.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July, 2023

  • 01.08.2023

    Announcements and Notices - [Discloseable Transaction / Connected Transaction] DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF NON-CONTROLLING INTEREST IN A SUBSIDIARY

  • 03.07.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June, 2023

  • 02.07.2023

    Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

  • 27.06.2023

    Constitutional Documents AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION

  • 27.06.2023

    Announcements and Notices - [List of Directors and their Role and Function] LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

  • 27.06.2023

    Announcements and Notices - [Results of AGM / Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member] POLL RESULTS OF ANNUAL GENERAL MEETING; RESIGNATION OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR; APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR; AND CHANGE IN COMPOSITION OF BOARD COMMITTEES

  • 01.06.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May, 2023

  • 23.05.2023

    Proxy Forms Proxy form for use at the annual general meeting (the "AGM") of Tianda Pharmaceuticals Limited to be held on Tuesday, 27 June 2023 at 10:30 a.m. (or at any adjournment thereof)

  • 23.05.2023

    Announcements and Notices - [Notice of AGM] NOTICE OF ANNUAL GENERAL MEETING

  • 23.05.2023

    Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents] PROPOSALS INVOLVING GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND RE-ELECTION OF RETIRING DIRECTORS; PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND THE SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION; AND NOTICE OF ANNUAL GENERAL MEETING

  • 19.05.2023

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] FINAL DIVIDEND FOR THE NINE MONTHS ENDED 31 DECEMBER 2022 (UPDATED)

  • 19.05.2023

    Announcements and Notices - [Dividend or Distribution / Closure of Books or Change of Book Closure Period] FINAL DIVIDEND FOR THE NINE MONTHS ENDED 31 DECEMBER 2022 CLOSURES OF REGISTER OF MEMBERS

  • 19.05.2023

    Announcements and Notices - [Amendment of Constitutional Documents] PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND THE SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION

  • 02.05.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April, 2023

  • 19.04.2023

    Announcements and Notices - [Connected Transaction] CONNECTED TRANSACTION SUBSCRIPTION OF INTEREST IN A FUND

  • 03.04.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March, 2023

  • 23.03.2023

    Announcements and Notices - [Dividend or Distribution (Announcement Form)] FINAL DIVIDEND FOR THE NINE MONTHS ENDED 31 DECEMBER 2022

  • 23.03.2023

    Announcements and Notices - [Final Results / Dividend or Distribution] FINAL RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 31 DECEMBER 2022

  • 19.03.2023

    Announcements and Notices - [Profit Warning / Inside Information] PROFIT ALERT

  • 10.03.2023

    Announcements and Notices - [Date of Board Meeting] DATE OF BOARD MEETING

  • 01.03.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February, 2023

  • 01.02.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January, 2023

  • 03.01.2023

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December, 2022

關注天大藥業:

  • About Us
    Company Profile Corporate Structure Milestones
  • Core Business
    R&D and Production Base Chinese Medicine Development Biomedical Technology and Products Quality Healthcare Services
  • Investor Relations
    Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications
  • Sustainability
    Our Sustainable Development ESG Reports
  • Careers
    Wort At Tianda Recruitment
  • Media Centre
    Press Releases Media Coverage Contact Us

Email AlertsPlease enter your email address

關注天大藥業:

  • Hong Kong Headquarters Level 24, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong

    Tel: +852 2545 3313

    Fax: +852 2541 6558

    Email: info@tianda.com

  • China, Regional Headquarters Level 28, Block C, Tian An International Building, 3012 Renmin Road South, Shenzhen, China

    (Postal code: 518001)

    Tel: +86 755 8228 3533

    Fax: +86 755 8228 9636

  • Australia, Regional HeadquartersSuite 3.03, Level 3, Macquarie Corporate Centre, 2 Banfield Road, Macquarie Park, NSW 2113, Australia

    Tel: +61 2 9251 9001

    Fax: +61 2 9251 7688

© Tianda Pharmaceuticals Limited. All Rights Reserved.
Disclaimer | Important Notice